Details
Stereochemistry | ACHIRAL |
Molecular Formula | C28H27NO4S.ClH |
Molecular Weight | 510.044 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=C(S2)C=C(O)C=C5
InChI
InChIKey=BKXVVCILCIUCLG-UHFFFAOYSA-N
InChI=1S/C28H27NO4S.ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29;/h4-13,18,30-31H,1-3,14-17H2;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C28H27NO4S |
Molecular Weight | 473.583 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:46:24 UTC 2023
by
admin
on
Fri Dec 15 15:46:24 UTC 2023
|
Record UNII |
4F86W47BR6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
EVISTA (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
OPTRUMA (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
||
|
FDA ORPHAN DRUG |
309910
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/10/730
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RALOXIFENE TEVA (AUTHORIZED: OSTEOPOROSIS, POSTMENOPAUSAL)
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
||
|
NCI_THESAURUS |
C1821
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL81
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
54900
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
706725
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
82640-04-8
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
U-8
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
DBSALT000272
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
1598201
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
DTXSID1034181
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
SUB12568MIG
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
100000091054
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
166551
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | RxNorm | ||
|
m9485
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | Merck Index | ||
|
C1762
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
50740
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
4F86W47BR6
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY | |||
|
4F86W47BR6
Created by
admin on Fri Dec 15 15:46:24 UTC 2023 , Edited by admin on Fri Dec 15 15:46:24 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
SOLVATE->ANHYDROUS |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
RALOXIFENE HYDROCHLORIDE IMPURITY B [EP] AMOUNT NOT SPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
RALOXIFENE HYDROCHLORIDE IMPURITY C [EP] AMOUNT NOT SPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |